Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 March
Protagenic Therapeutics, Inc.\new has filed 705 SEC EDGAR filings since 22 Oct 1996

SEC filing history

Showing 276-300 of 448 matching filings.

Per page
25
Current page
12
4

FORM 4

Filing date
18 Aug 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Aug 2016
Reporting date
08 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51353

FORM 8-K

Filing date
15 Jul 2016
Reporting date
25 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-51353

FORM 8-K/A

Filing date
12 Jul 2016
Reporting date
12 Feb 2016
Next action
Verify source filing
SC 13D/A File 005-48089

SCHEDULE 13D/A

Filing date
23 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51353

FORM 8-K

Filing date
20 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-51353

FORM NT 10-Q

Filing date
17 May 2016
Reporting date
31 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 000-51353

DEFR14A

Filing date
04 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51353

DEF 14A

Filing date
03 May 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-257945

D/A filing

Filing date
22 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-257945

D/A filing

Filing date
22 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-51353

PRE 14A

Filing date
20 Apr 2016
Reporting date
20 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-51353

8-K/A

Filing date
20 Apr 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51353

FORM 8-K

Filing date
18 Apr 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51353

FORM 8-K

Filing date
07 Apr 2016
Reporting date
04 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .